93 related articles for article (PubMed ID: 17337388)
1. [Aberrant methylation of tumor suppressor genes in head and neck squamous cell carcinoma: is it clinically relevant?].
Righini CA; de Fraipont F; Reyt E; Favrot MC
Bull Cancer; 2007 Feb; 94(2):191-7. PubMed ID: 17337388
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
Righini CA; de Fraipont F; Timsit JF; Faure C; Brambilla E; Reyt E; Favrot MC
Clin Cancer Res; 2007 Feb; 13(4):1179-85. PubMed ID: 17317827
[TBL] [Abstract][Full Text] [Related]
3. [Biallelic inactivation of the p16-Gen in a metachronous triple carcinoma in the oropharyngeal region].
Motsch C; Giers A; Boltze C; Evert M; Freigang B; Roessner A; Schneider-Stock R
Laryngorhinootologie; 2004 Jan; 83(1):55-60. PubMed ID: 14740307
[TBL] [Abstract][Full Text] [Related]
4. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
Koscielny S; V Eggeling F; Dahse R
Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
[TBL] [Abstract][Full Text] [Related]
5. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
6. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D
Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
9. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
10. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
11. [Aberrant methylation of tumor suppressor genes in renal cell carcinoma].
Zhang Q; Jin J; Tao Q
Ai Zheng; 2007 Nov; 26(11):1276-80. PubMed ID: 17991333
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
[TBL] [Abstract][Full Text] [Related]
13. DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas.
Wu CL; Roz L; McKown S; Sloan P; Read AP; Holland S; Porter S; Scully C; Paterson I; Tavassoli M; Thakker N
Genes Chromosomes Cancer; 1999 May; 25(1):16-25. PubMed ID: 10221335
[TBL] [Abstract][Full Text] [Related]
14. Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines.
Imura M; Yamashita S; Cai LY; Furuta J; Wakabayashi M; Yasugi T; Ushijima T
Cancer Lett; 2006 Sep; 241(2):213-20. PubMed ID: 16303245
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
16. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.
Okuda H; Toyota M; Ishida W; Furihata M; Tsuchiya M; Kamada M; Tokino T; Shuin T
Oncogene; 2006 Mar; 25(12):1733-42. PubMed ID: 16278676
[TBL] [Abstract][Full Text] [Related]
18. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma.
Nagata S; Hamada T; Yamada N; Yokoyama S; Kitamoto S; Kanmura Y; Nomura M; Kamikawa Y; Yonezawa S; Sugihara K
Cancer; 2012 Sep; 118(17):4298-308. PubMed ID: 22252571
[TBL] [Abstract][Full Text] [Related]
19. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications.
Maruya S; Issa JP; Weber RS; Rosenthal DI; Haviland JC; Lotan R; El-Naggar AK
Clin Cancer Res; 2004 Jun; 10(11):3825-30. PubMed ID: 15173091
[TBL] [Abstract][Full Text] [Related]
20. [The roles of DNA methylation in human neoplasms].
Yuan YF; Li JQ; Yang ZL; Wang JP
Ai Zheng; 2002 Nov; 21(11):1267-77. PubMed ID: 12526230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
